Your browser doesn't support javascript.
loading
NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.
Pontarini, Elena; Sciacca, Elisabetta; Grigoriadou, Sofia; Rivellese, Felice; Lucchesi, Davide; Fossati-Jimack, Liliane; Coleby, Rachel; Chowdhury, Farzana; Calcaterra, Francesca; Tappuni, Anwar; Lewis, Myles J; Fabris, Martina; Quartuccio, Luca; Bella, Silvia Della; Bowman, Simon; Pitzalis, Costantino; Mavilio, Domenico; De Vita, Salvatore; Bombardieri, Michele.
Affiliation
  • Pontarini E; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, United Kingdom.
  • Sciacca E; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, United Kingdom.
  • Grigoriadou S; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, United Kingdom.
  • Rivellese F; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, United Kingdom.
  • Lucchesi D; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, United Kingdom.
  • Fossati-Jimack L; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, United Kingdom.
  • Coleby R; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, United Kingdom.
  • Chowdhury F; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, United Kingdom.
  • Calcaterra F; Institute of Dentistry, Barts and the London School of Medicine and Dentistry, London, United Kingdom.
  • Tappuni A; Laboratory of Clinical and Experimental Immunology, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano, Italy.
  • Lewis MJ; Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy.
  • Fabris M; Institute of Dentistry, Barts and the London School of Medicine and Dentistry, London, United Kingdom.
  • Quartuccio L; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, United Kingdom.
  • Bella SD; Istituto Di Patologia Clinica, Azienda Sanitaria Universitaria Integrata di Udine (ASUID), Udine, Italy.
  • Bowman S; Clinic of Rheumatology, Department of Medicine (DAME), University of Udine, School of Rheumatology, Academic Hospital "Santa Maria della Misericordia", Udine, Italy.
  • Pitzalis C; Laboratory of Clinical and Experimental Immunology, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano, Italy.
  • Mavilio D; Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy.
  • De Vita S; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham National Health System (NHS) Foundation Trust, Birmingham, United Kingdom.
  • Bombardieri M; Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, London, United Kingdom.
Front Immunol ; 12: 706737, 2021.
Article de En | MEDLINE | ID: mdl-34594326

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glandes salivaires / Syndrome de Gougerot-Sjögren / Récepteur-3 de déclenchement de cytotoxicité naturelle / Structures lymphoïdes tertiaires Limites: Humans Langue: En Journal: Front Immunol Année: 2021 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glandes salivaires / Syndrome de Gougerot-Sjögren / Récepteur-3 de déclenchement de cytotoxicité naturelle / Structures lymphoïdes tertiaires Limites: Humans Langue: En Journal: Front Immunol Année: 2021 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Suisse